Ladenburg Thalmann downgraded CONMED (NASDAQ: CNMD) from Buy to Neutral with a price target of $55 (unchanged).

For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.

Shares of CONMED closed at $54.23 yesterday.